Manchanda S, Rizvi QUA, Singh R. Role of endoscopy in the surveillance and management of colorectal neoplasia in inflammatory bowel disease. World J Clin Cases 2019; 7(1): 1-9 [PMID: 30637247 DOI: 10.12998/wjcc.v7.i1.1]
Corresponding Author of This Article
Rajvinder Singh, FRACP, FRCP(C), MBBS, MPhil, MRCP, Professor, Department of Gastroenterology, Lyell McEwin Hospital, Haydown Road, Elizabeth Vale, Adelaide, South Australia 5112, Australia. rajvinder.singh@sa.gov.au
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Minireviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Shaad Manchanda, Rajvinder Singh, Department of Gastroenterology, Lyell McEwin Hospital, South Australia 5112, Australia
Shaad Manchanda, Rajvinder Singh, School of Medicine, University of Adelaide, South Australia 5000, Australia
Qurat-ul-ain Rizvi, Eastern Health, Department of Gastroenterology, Box Hill Hospital, Victoria 3128, Australia
Author contributions: Manchanda S, Rizvi Q and Singh R contributed equally to this work.
Conflict-of-interest statement: The authors have no conflicts of interest.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Rajvinder Singh, FRACP, FRCP(C), MBBS, MPhil, MRCP, Professor, Department of Gastroenterology, Lyell McEwin Hospital, Haydown Road, Elizabeth Vale, Adelaide, South Australia 5112, Australia. rajvinder.singh@sa.gov.au
Telephone: +61-8-81829000 Fax: +61-8-82821764
Received: October 27, 2018 Peer-review started: October 29, 2018 First decision: November 27, 2018 Revised: December 19, 2018 Accepted: December 21, 2018 Article in press: December 21, 2018 Published online: January 6, 2019 Processing time: 69 Days and 6.8 Hours
Abstract
Endoscopy has become increasingly fundamental in the management of patients with inflammatory bowel disease (IBD). It is required for diagnosis, assessment of therapeutic response, postoperative follow up and in the surveillance of dysplasia. With rapid advances in technology, including high definition colonoscopy and chromoendoscopy, questions have arisen regarding the most appropriate surveillance and management strategies of colorectal neoplasia in IBD. We aim to review current surveillance strategies, explore the utility of new technologies, and examine the role of endoscopic resection, with the aim of clarifying these questions.
Core tip: With the use of new generation, high definition endoscopy, most dysplasia is visually identifiable and hence targeted biopsies are advised. Random biopsies may be utilised in patients with a personal history of neoplasia, primary sclerosis cholangitis, and a tubular colon. Any lesion deemed to be endoscopically resectable should be referred to centres with expertise to do so whilst invisible dysplasia should prompt consideration towards a colectomy.
